BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CSL Behring 

1020 First Avenue
P.O. Box 61501
King of Prussia  Pennsylvania  19406-0901  U.S.A.
Phone: 610-878-4000 Fax: 610-878-4009


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
CSL Behring Release: Study Suggests C1-INH May Aid In Prevention Of Antibody-Mediated Rejection Following Kidney Transplant 7/30/2014 9:45:37 AM
CSL Behring Announces The 2014 Interlaken Leadership Awards Recipient 6/24/2014 8:26:41 AM
CSL Behring Launches Hizentra® Co-Pay Relief Program 5/20/2014 8:39:49 AM
CSL Behring Opens World-Class, Advanced Manufacturing Facility For Late-Stage Production Of Hemophilia Therapies Now In Development 5/9/2014 8:19:16 AM
CSL Behring Enrolls First Patient In Global Pediatric Phase 3 Pivotal Study Of Recombinant Factor VIII Single Chain (Rviii-Singlechain) To Treat Severe Hemophilia A 5/2/2014 8:44:25 AM
CSL Behring Continues Commitment To Donate Bleeding Disorder Medications To World Federation of Hemophilia 4/17/2014 1:24:11 PM
CSL Behring Launches My Access™ Cost Share Program During Hemophilia Awareness Month 3/27/2014 9:19:59 AM
CSL Behring And CSL Plasma Employees Open Their Hearts To Those In Need 2/20/2014 9:53:01 AM
CSL Behring Release: First Patient Enrolled In Phase III Of COMPACT, A Study Of Volume-Reduced Subcutaneous C1-INH For Prevention Of Hereditary Angioedema (HAE) Attacks 2/20/2014 9:51:30 AM
CSL Behring's Kcentra® Receives FDA Approval For Use In Warfarin Reversal In Patients Undergoing Surgery 12/16/2013 7:06:18 AM
12345678910...